HealthcareServices

Visceral Pain Market Report 2026: Strategic Insights and Revenue Outlook

March 4, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the visceral pain market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Visceral Pain Market?

The visceral pain market size has demonstrated robust expansion over recent years. It is anticipated to increase from $14.82 billion in 2025 to $15.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.9%. This historical growth can be attributed to several factors, including the rising occurrence of gastrointestinal and pelvic disorders, broader utilization of NSAIDs and calcium channel blockers, improved clinical detection of visceral pain conditions, the proliferation of hospital-based pain management services, and the availability of diverse drug classes.

The market for visceral pain is anticipated to experience substantial growth in the upcoming years, projected to reach $19.6 billion by 2030 with a compound annual growth rate of 5.7%. This expansion during the forecast period is attributed to several factors, including a rising demand for tailored pain therapies, an increased focus on chronic pain management, the broader implementation of precision medicine approaches, a greater adoption of advanced diagnostic instruments, and augmented investments in the creation of non-opioid drugs. Prominent trends throughout this period involve the increasing embrace of targeted pain management treatments, a growing reliance on multimodal drug combinations, a stronger emphasis on non-opioid treatment alternatives, the development of personalized visceral pain management strategies, and an enhanced focus on early diagnosis and intervention.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

Which Drivers Are Supporting The Rise Of The Visceral Pain Market?

The escalating demand for analgesics is anticipated to drive the expansion of the visceral pain market in the future. Analgesics are drugs designed to ease pain by lessening or blocking the brain’s interpretation of pain signals. These medications help control visceral pain by targeting the nervous system and adjusting pain signals originating from internal organs. For instance, in April 2024, as per the New England Journal of Medicine, a UK-based weekly medical journal, over 53,600 clinicians were prescribing buprenorphine by December 2023, which signifies an increase of 11,500 prescribers compared to December 2022. Therefore, the growing need for analgesics is propelling the growth of the visceral pain market.

What Leading Segments Are Studied In The Visceral Pain Market?

The visceral pain market covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs

3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

How Are Emerging Trends Affecting The Progression Of The Visceral Pain Market?

Entities operating within the chronic pain market are increasingly focused on conducting clinical trials to innovate products like NOP receptor agonists, aiming to provide effective pain relief while potentially mitigating the risks associated with opioid-based treatments. NOP receptor agonists are compounds designed to activate the nociceptin/orphanin FQ peptide receptor, which plays a role in modulating pain signaling in the nervous system; these help alleviate chronic and visceral pain without the high risk of addiction or severe side effects typically linked to traditional opioids. For instance, in October 2024, Grünenthal GmbH, a Germany-based pharmaceutical company, commenced a first-in-human Phase I clinical trial, enlisting 90 healthy participants to evaluate the safety, tolerability, and pharmacokinetics of its novel NOP receptor agonist. This study aims to assess the investigational compound’s potential to deliver potent and safe pain relief across various chronic pain conditions, thus introducing a new therapeutic approach for managing both somatic and visceral pain.

Which Key Players Are Driving Competition In The Visceral Pain Market?

Major companies operating in the visceral pain market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

Which Region Is Projected To Lead The Visceral Pain Market During The Forecast Period?

North America was the largest region in the visceral pain market in 2025. The regions covered in the visceral pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Visceral Pain Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13950&type=smp

Browse Through More Reports Similar to the Global Visceral Pain Market 2026, By The Business Research Company

Ulcerative Colitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795